‘Faster, Better, More Efficient’ – Why Bayer Is Investing in ‘Precision Health’
Article
Commercial
Like other big global OTC players, Bayer Consumer Health is stepping up its investment in digital self-care. In the first part of an exclusive two-part interview, HBW Insight interviews the company's head of R&D and chief scientific officer David Evendon-Challis to dig deeper into the rationale for setting up a new 'precision health' business unit.
There are predictions that precision health will be up to 20% of the consumer health market.
